Cardiovascular disease risk factors and lifestyle modification strategies after pediatric kidney transplantation: what are we dealing with, and what can we target?

被引:3
|
作者
Bae, Se Ri [1 ]
Bicki, Alexandra [2 ]
Coufal, Sarah [3 ,4 ]
Jin, Ethan [5 ]
Ku, Elaine [2 ,3 ,4 ]
机构
[1] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, Dept Pediat, Div Pediat Nephrol, San Francisco, CA 94115 USA
[3] Univ Calif San Francisco, Div Nephrol, Dept Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[5] Touro Univ, Coll Osteopath Med, Vallejo, CA USA
关键词
Pediatric; Kidney; Transplant; Obesity; Hypertension; Dyslipidemia; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; BLOOD-PRESSURE; RENAL-TRANSPLANTATION; EXERCISE CAPACITY; YOUNG-ADULTS; CHILDREN; HYPERTENSION; MANAGEMENT; DIETS;
D O I
10.1007/s00467-022-05589-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Kidney transplantation in pediatric patients can lead to partial improvement of some of the cardiometabolic parameters that increase the risk for cardiovascular disease (CVD) in patients with chronic kidney disease. However, even after restoration of kidney function, transplant recipients remain at risk for CVD due to the continual presence of traditional and non-traditional risk factors, including the side effects of immunosuppression and chronic inflammation. This educational review describes the prevalence of CVD risk factors in pediatric kidney transplant recipients and presents available evidence for therapeutic lifestyle changes and other non-pharmacologic strategies that can be used to improve traditional and modifiable CVD risk factors. Although trial-grade evidence for interventions that improve CVD in pediatric kidney transplant recipients is limited, potential strategies include lowering dietary sodium and saturated fat intake and increasing physical activity levels. Intensive follow-up may help patients achieve guideline-recommended goals for reducing their overall CVD risk.
引用
收藏
页码:663 / 671
页数:9
相关论文
共 21 条
  • [21] To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3-5 non-dialysis patients?
    Dincer, Mevlut Tamer
    Ozcan, Seyda Gul
    Alagoz, Selma
    Karaca, Cebrail
    Gulcicek, Sibel Hamarat
    Trabulus, Sinan
    Pekpak, Meltem
    Seyahi, Nurhan
    CLINICAL NEPHROLOGY, 2022, 98 (05) : 239 - 246